Welcome!
Acumen Diagnostics
Broker's Calls
CGS-CIMB updates Q&M to 'add' as Acumen's tender win alleviates short-term pressure
"We believe valuations have turned attractive for Q&M": CGS-CIMB as their FY2023 earnings note negligible contribution from Acumen
October 13, 2022
Corporate moves
Q&M Dental banks on AI tech after Covid-19 high
Q&M is coming off its Covid-19 high, but it intends to ride on another boom.
July 07, 2022
Broker's Calls
CGS-CIMB expects earnings momentum to ease for Q&M; valuation remains attractive
Q&M's earnings growth momentum is expected to ease but at 15.2 times P/E and a dividend yield of 7%, the stock is still attractive
February 11, 2022
Stocks To Watch
Q&M Dental Group: Outlook bright with expansion and a spin-off
Bright smiles ahead for Q&M Dental Group.
January 27, 2022
Broker's Calls
Potential listing of Acumen on Nasdaq may boost Q&M and Aoxin Q&M: UOBKH
Acumen's potential listing on Nasdaq bodes well for both Aoxin Q&M and Q&M Dental.
January 24, 2022
Covid-19
Q&M's Acumen Diagnostics granted MOH Covid-19 offsite PCR testing license
PCR testing services will be rolled out to 10 clinics by Dec 31.
December 16, 2021
Covid-19
Q&M's Acumen Diagnostics says PCR test kits able to detect Omicron variant
This is in addition to being able to detect Covid-19 cases infected with the Delta variant, says the group.
December 03, 2021
M&A
Aoxin Q&M acquires 49% stake in Q&M's Acumen for $29.4 mil
Q&M, which owns a 32.95% stake in Aoxin Q&M, will have effective ownership of 67.15% in Acumen post-transaction.
October 04, 2021
Broker's Calls
UOB Kay Hian starts Q&M Dental at 'buy' on twin growth engines and Covid-19 testing business
UOB Kay Hian's target price of 94 cents is pegged to 20 times FY2022 price-to-earnings (P/E).
June 29, 2021
Covid-19
Q&M’s Acumen receives approval from MOH to provide offsite Covid-19 testing
Shares in Q&M closed 1 cent lower or 1.4% down at 68 cents on June 4.
June 04, 2021